All In Biotech

Drug Trial Radar · NCT03393013

A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis

A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis (MISSION)

Last checked: Nov 20, 2026Latest source record: Nov 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

69

Actual

Start

Feb 20, 2018

Primary completion

Aug 4, 2022

Study completion Aug 4, 2022

Sponsor

Lead sponsor
Kezar Life Sciences, Inc.Industry
Sponsor type
Industry
First posted
Jan 8, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This was a Phase 1b/2, multi-center study in which patients received KZR-616, administered as a subcutaneous (SC) injection weekly for 13 weeks (Phase 1b) or 24 weeks (Phase 2).

Conditions

  • Lupus Nephritis
  • Systemic Lupus Erythematosus

Interventions

  • KZR-616Drug

    Subcutaneous Injection of KZR-616

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1b: Number of Patients Who Experienced at Least One Treatment-Related Treatment-Emergent Adverse EventTime frame: 25 weeks
  2. Phase 2: Number of Patients With Lupus Nephritis With a 50% Reduction in UPCRTime frame: 24 weeks

Locations

36 sites in 8 countries. Site status is shown where the registry gives one.

  • Academic Medical Research Institute

    Los Angeles, California

  • Inland Rheumatology Clinical Trials, Inc.

    Upland, California

  • SouthCoast Research Center, Inc.

    Miami, Florida

  • Hope Clinical Trials, Inc.

    Miami, Florida

  • Omega Research Maitland

    Orlando, Florida

  • Arthritis Center, Inc

    Palm Harbor, Florida

  • Advent Health Medical Group

    Tampa, Florida

  • University of Iowa

    Iowa City, Iowa

  • Northwell Health

    Great Neck, New York

  • NYU Langone Orthopedic Center - Seligman Center for Advanced Therapeutics

    New York, New York

  • University of Rochester Medical Center

    Rochester, New York

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • SC Nephrology & Hypertension Center, Inc.

    Orangeburg, South Carolina

  • Ramesh C. Gupta, MD

    Memphis, Tennessee

  • MedResearch, Inc.

    El Paso, Texas

  • Accurate Clinical Research, Inc.

    Houston, Texas

  • Accurate Clinical Management, LLC

    Houston, Texas

  • Monash Health

    Clayton, Victoria, Australia

  • The Royal Melbourne Hospital

    Parkville, Victoria, Australia

  • Centro Integral de Reumatologia de Caribe CIRCARIBE S.A.S

    Barranquilla, Atlántico, Colombia

  • Clinica de la Costa

    Barranquilla, Atlántico, Colombia

  • Medicity SAS

    Santander, Bucaramanga, Colombia

  • Servimed S.A.S.

    Bucaramanga, Santander Department, Colombia

  • Clinica de Artritis Temprana

    Cali, Valle del Cauca Department, Colombia

  • Instituto Nacional de Cardiología Ignacio Chavez

    Mexico City, Mexico

  • Instituto Nacional de Ciencias Médicas y Nutricion "Salvador Zubiran"

    Mexico City, Mexico

  • Centro Integral de Reumatologia SA de CV

    Guadalajara, Jalisco, Mexico

  • Hospital Universitario Dr José Eleuterio Gonzalez

    Monterrey, Nuevo León, Mexico

  • Investigaciones Clinicas SAC

    Lima, Peru

  • Unidad de Investigacion en Reumatologia e Inmunologia Clinica San Juan Bautista

    Lima, Peru

  • Centro de Investigación Clínica Trujillo E.I.R.L/ Clínica Peruano Americana S.A.

    Trujillo, La Libertad, Peru

  • Bioclinica

    Lodz, Poland

  • Kuzbass Clinical Hospital

    Kemerovo, Russia

  • Medical Center Revma-Med

    Kemerovo, Russia

  • Tolyatti City Clinical Hospital #1

    Tolyatti, Russia

  • Harmoniya Krasy

    Kyiv, Kyiv Governorate, Ukraine

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.